Xiaoyun Pan

932 total citations
41 papers, 671 citations indexed

About

Xiaoyun Pan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Xiaoyun Pan has authored 41 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 10 papers in Economics and Econometrics. Recurrent topics in Xiaoyun Pan's work include Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (7 papers) and Economic and Financial Impacts of Cancer (6 papers). Xiaoyun Pan is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Colorectal Cancer Treatments and Studies (7 papers) and Economic and Financial Impacts of Cancer (6 papers). Xiaoyun Pan collaborates with scholars based in United States, Switzerland and Germany. Xiaoyun Pan's co-authors include Usha Sambamoorthi, Ami Vyas, Huamao Mark Lin, Shiwei Gong, Mohammad Jahanzeb, Si Jin, Weixia Zhang, Nan Chen, Bo Zhu and Wei Wang and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Xiaoyun Pan

34 papers receiving 657 citations

Peers

Countries citing papers authored by Xiaoyun Pan

Since Specialization

Citations

This map shows the geographic impact of Xiaoyun Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyun Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyun Pan more than expected).

Fields of papers citing papers by Xiaoyun Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyun Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyun Pan. The network helps show where Xiaoyun Pan may publish in the future.

Co-authorship network of co-authors of Xiaoyun Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyun Pan. A scholar is included among the top collaborators of Xiaoyun Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyun Pan. Xiaoyun Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-World Study of Patients with Metastatic Colorectal Cancer and Long-Term Response to Regorafenib in the USA 2025 ·Cancers ·Richard D. Kim, Xiaoyun Pan, (unknown), Orsolya Lunacsek, Federica Pisa, (unknown), Marc Peeters	0
2	Development of a PSMA and EphA2 dual-receptor-activated fluorescent probe for wash-free prostate cancer cell imaging 2025 ·Bioorganic & Medicinal Chemistry ·Xiaoyun Pan, Xiao Wang, (unknown), Xing Yang	1
3	Sequential Treatment with Regorafenib and Trifluridine/Tipiracil ± Bevacizumab in Refractory Metastatic Colorectal Cancer in Community Clinical Practice in the USA 2025 ·Cancers ·Daniel H. Ahn, Tanios Bekaii‐Saab, (unknown), Milena Kurtinecz, Xiaoyun Pan, Zdravko P. Vassilev, Federica Pisa, (unknown)	0
4	Real-World Systemic Treatment Patterns after Atezolizumab and Bevacizumab in Patients with Hepatocellular Carcinoma in the United States 2023 ·Cancers ·Amit G. Singal, (unknown), Xiaozhou Fan, Zdravko P. Vassilev, Xiaoyun Pan, (unknown), Chi‐Chang Chen, (unknown), (unknown), Federica Pisa	8
5	Immunotherapy Treatment Patterns and Outcomes Among ALK-Positive Patients With Non–Small-Cell Lung Cancer 2020 ·Clinical Lung Cancer ·Mohammad Jahanzeb, Huamao Mark Lin, Xiaoyun Pan, Yu Yin, Pia Baumann, Corey J. Langer	47
6	PCN308 REAL-WORLD UTILIZATION OF BRIGATINIB IN PATIENTS WITH NON–SMALL CELL LUNG CANCER (NSCLC) 2019 ·Value in Health ·(unknown), Xiaoyun Pan, Peijie Hou, Hui Huang, Pia Baumann, Mohammad Jahanzeb	1
7	Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China 2018 ·PLoS ONE ·(unknown), Zhiguo Zhang, (unknown), (unknown), Xiaoyun Pan, Liang Zhang, Shiwei Gong, Si Jin	67
8	Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer 2017 ·Journal of the National Comprehensive Cancer Network ·Ami Vyas, S. Suresh Madhavan, Usha Sambamoorthi, Xiaoyun Pan, Michael Regier, Hannah Hazard‐Jenkins, (unknown)	13
9	Initiation of triple therapy maintenance treatment among patients with COPD in the US 2016 ·International Journal of COPD ·Jason C. Simeone, (unknown), Shuchita Kaila, Xiaoyun Pan, Tarun Bhagnani, (unknown), Teresa K. Wilcox	59
10	The availability and affordability of orphan drugs for rare diseases in China 2016 ·Orphanet Journal of Rare Diseases ·Shiwei Gong, Yingxiao Wang, Xiaoyun Pan, Liang Zhang, Rui Huang, Xin Chen, Juanjuan Hu, Yi Xu, Si Jin	53
11	Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis 2016 ·Journal of Managed Care & Specialty Pharmacy ·Yanni Yu, Ning Wu, (unknown), (unknown), Xiaoyun Pan, (unknown), Giovanna Devercelli, David Coultas	33
12	Treatment and Survival of Medicare Beneficiaries with Colorectal Cancer: A Comparative Analysis Between a Rural State Cancer Registry and National Data 2016 ·Population Health Management ·Pallavi Rane, S. Suresh Madhavan, Usha Sambamoorthi, (unknown), Sobha Kurian, Xiaoyun Pan	3
13	Health care expenditures associated with depression in adults with cancer 2015 ·The Journal of Community and Supportive Oncology ·Xiaoyun Pan, Usha Sambamoorthi	36
14	Fda Cdx Category Medication Use During Pregnancy in the United States 2014 ·Value in Health ·Amit D. Raval, Xiaoyun Pan, Usha Sambamoorthi	1
15	Triptan Use For Migraine Headache Among Adults With Cardiovascular Risk 2014 ·Value in Health ·Monira Alwhaibi, Xiaoyun Pan, Usha Sambamoorthi	0
16	Treatment and Survival Patterns Among Elderly Medicare Beneficiaries with Colorectal Cancer: A Comparative Analysis Between a Rural State Cancer Registry and National Data 2014 ·Value in Health ·Pallavi Rane, S. Suresh Madhavan, Usha Sambamoorthi, (unknown), (unknown), Xiaoyun Pan	0
17	Adalimumab real-world dosage pattern and predictors of weekly dosing: Patients with Crohn's disease in the United States 2011 ·Journal of Crohn s and Colitis ·Edward V. Loftus, Xiaoyun Pan, (unknown), Parvez Mulani, Jingdong Chao	10
18	Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines 2011 ·Leukemia & lymphoma ·Brian K. Link, John M. Brooks, Kara Wright, Xiaoyun Pan, Margaret D. Voelker, Elizabeth A. Chrischilles	30
19	Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials 2007 ·Nephrology Dialysis Transplantation ·Bo Zhu, Nan Chen, Yan Lin, Hong Ren, Weixia Zhang, Wei Wang, Xiaoyun Pan, Hee Chul Yu	93
20	Osteoporosis risk screening for women in a community pharmacy 2007 ·Journal of the American Pharmacists Association ·Yifei Liu, (unknown), (unknown), William R. Doucette, Randal P. McDonough, Xiaoyun Pan	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact